Back to Stock Universe
Daily Decision Engine
ALIVUSLIFESCIENCES
Alivus Life Sciences Ltd · Healthcare · API / Generic Pharmaceuticals · Small Cap
HOLD with net score +2 (+6 buy, −4 sell). Strongest positive: VR Stock Rating Strong (weight 4). 2 BUY rules fire total. Caution: PEG Stretched (weight 2) flags risk.
Engine Verdict
Hold
Score
+2
Buy
+6
Sell
−4
Veto
—
Price Context
Current Price
₹1,108.30
1M
+6.67%
1Y
+11.60%
3Y
+25.44%
52W Low ₹819.00Now ₹1,108.3052W High ₹1,148.40
Price History (Yahoo) with Your Decisions
No price data returned for this ticker.
Returns Profile
VR Score Radar (out of 10)
Verdict Breakdown · 4 triggered / 21 active
VR Stock Rating StrongBUYw4
VR Stock Rating (1-5) ≥ 4 → 4.00
Strong FCF YieldBUYw2
FCF Yield % > 5 → 5.36
PEG StretchedSELLw2
PEG > 2.5 → 2.71
Momentum OverextendedSELLw2
VR Momentum Score (1-10) ≥ 9 → 9.00
P/E Below Its 5Y MedianBUYw2
P/E vs Median % < 0 → 15.52
Failed: P/E vs Median % = 15.52 is not < 0.
P/B Below Its 5Y MedianBUYw2
P/B vs Median % < 0 → 7.21
Failed: P/B vs Median % = 7.21 is not < 0.
VR Valuation Score StrongBUYw2
VR Valuation Score (1-10) ≥ 6 → 5.00
Failed: VR Valuation Score (1-10) = 5.00 is not ≥ 6.
Cheap on EV/EBITDABUYw2
EV / EBITDA < 12 → 15.82
Failed: EV / EBITDA = 15.82 is not < 12.
⚠️ 1 rule couldn't evaluate due to missing data
Columns missing from your upload: 5Y Return %. Use VR's Stock Advisor "Recommendations" export (44 columns) for full coverage.
VR Proprietary Scores
VR Stock Rating
4 / 5 ⭐
Quality
8/10
Growth
6/10
Valuation
5/10
Momentum
9/10
Fundamentals
P/E
24.05
vs 5Y median 20.82 · +15.5%
P/B
4.07
vs 5Y median 3.80 · +7.2%
EV/EBITDA
15.82
Price / CFO
34.66
Price / Sales
5.32
PEG
2.71
From VR
Earning Yield %
5.51
From VR
Dividend Yield %
0.45
FCF / Share
59.35
→ FCF Yield 5.36%
EPS
47.59
Market Cap
13571.30 Cr
Enterprise Value
13150.10 Cr
Engine Zone Timeline · 2 runs
06-25+2
06-26+2
STRONG BUY
BUY
HOLD
SELL
STRONG SELL
AVOID
Your Decisions on ALIVUSLIFESCIENCES · 0
No decisions logged on this stock yet.
Use “Log Decision” above to start your trade journal. Every decision will appear here with hindsight grade.
Position Lifecycle · ALIVUSLIFESCIENCES
No position taken yet
You've only WATCHED / SKIPPED so far. Log a BUY decision to begin the lifecycle.
Recent News · ALIVUSLIFESCIENCES
No recent news found
Yahoo Finance returned no headlines for ticker ALIVUSLIFESCIENCES.NS.
If this ticker looks wrong (e.g. should be INFY.NS not INFOSYS.NS), open Symbol Aliases and set the correct Yahoo ticker.
Sector Peers
Comparing against 5 peers matched by sector: API / Generic Pharmaceuticals
| Stock | Zone | Price | Mcap | P/E | P/B | ROE % | ROCE % | D/E | EPS g% | Div Y% | 1Y Ret % | Quality |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALIVUSLIFESCIENCESYOU Alivus Life Sciences Ltd | Hold | 1,108.30 | ₹136B | 24.05 | 4.07 | — | — | — | — | 0.45 | 11.60 | 8/10 |
| SUNPHARMACEUTICALIND Sun Pharmaceutical Industries Ltd. | Buy | 1,862.80 | ₹4.48T | 39.00 | 5.36 | — | — | — | — | 0.86 | 12.10 | 8/10 |
| CIPLA Cipla Ltd. | Hold | 1,440.10 | ₹1.17T | 30.18 | 3.41 | — | — | — | — | 0.90 | -4.15 | 8/10 |
| ZYDUSLIFESCIENCES Zydus Lifesciences Ltd. | Buy | 1,101.40 | ₹1.10T | 21.83 | 4.23 | — | — | — | — | 0.09 | 14.19 | 9/10 |
| GLAXOSMITHKLINEPHARM Glaxosmithkline Pharmaceuticals Ltd. | Hold | 2,354.80 | ₹398B | 38.44 | 17.44 | — | — | — | — | 2.43 | -27.08 | 10/10 |
| AJANTAPHARMA Ajanta Pharma Ltd. | Hold | 3,180.40 | ₹398B | 37.68 | 8.80 | — | — | — | — | 0.88 | 24.03 | 7/10 |
Green = peer is better than you on that metric (lower for valuation, higher for quality/growth). Click any peer to deep-dive.
AI Deep Dive (Claude)
Daily quota: 0 / 5
No AI analysis yet
Click 'Generate' to have Claude write a bull-case / bear-case / verdict-flip analysis using all the data on this page.
Ask Claude about this stock
Discuss ALIVUSLIFESCIENCES with AI0/30 today
Ask anything about ALIVUSLIFESCIENCES
I have your fundamentals, all 21 rule evaluations, recent analysis, and your decision journal in context.